195 related articles for article (PubMed ID: 27542176)
1. Narciclasine - an Amaryllidaceae Alkaloid with Potent Antitumor and Anti-Inflammatory Properties.
Fürst R
Planta Med; 2016 Nov; 82(16):1389-1394. PubMed ID: 27542176
[TBL] [Abstract][Full Text] [Related]
2. Human cytochrome P450 liability studies of trans-dihydronarciclasine: a readily available, potent, and selective cancer cell growth inhibitor.
McNulty J; Thorat A; Vurgun N; Nair JJ; Makaji E; Crankshaw DJ; Holloway AC; Pandey S
J Nat Prod; 2011 Jan; 74(1):106-8. PubMed ID: 21105682
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship analysis of novel derivatives of narciclasine (an Amaryllidaceae isocarbostyril derivative) as potential anticancer agents.
Ingrassia L; Lefranc F; Dewelle J; Pottier L; Mathieu V; Spiegl-Kreinecker S; Sauvage S; El Yazidi M; Dehoux M; Berger W; Van Quaquebeke E; Kiss R
J Med Chem; 2009 Feb; 52(4):1100-14. PubMed ID: 19199649
[TBL] [Abstract][Full Text] [Related]
4. Isolation, Synthesis, and Semisynthesis of Amaryllidaceae Constituents from Narcissus and Galanthus sp.: De Novo Total Synthesis of 2- epi-Narciclasine.
Borra S; Lapinskaite R; Kempthorne C; Liscombe D; McNulty J; Hudlicky T
J Nat Prod; 2018 Jun; 81(6):1451-1459. PubMed ID: 29787267
[TBL] [Abstract][Full Text] [Related]
5. Narciclasine inhibits angiogenic processes by activation of Rho kinase and by downregulation of the VEGF receptor 2.
Bräutigam J; Bischoff I; Schürmann C; Buchmann G; Epah J; Fuchs S; Heiss E; Brandes RP; Fürst R
J Mol Cell Cardiol; 2019 Oct; 135():97-108. PubMed ID: 31381906
[TBL] [Abstract][Full Text] [Related]
6. The Amaryllidaceae isocarbostyril narciclasine induces apoptosis by activation of the death receptor and/or mitochondrial pathways in cancer cells but not in normal fibroblasts.
Dumont P; Ingrassia L; Rouzeau S; Ribaucour F; Thomas S; Roland I; Darro F; Lefranc F; Kiss R
Neoplasia; 2007 Sep; 9(9):766-76. PubMed ID: 17898872
[TBL] [Abstract][Full Text] [Related]
7. Antineoplastic agents. 587. Isolation and structure of 3-epipancratistatin from Narcissus cv. Ice Follies.
Pettit GR; Tan R; Bao GH; Melody N; Doubek DL; Gao S; Chapuis JC; Williams L
J Nat Prod; 2012 Apr; 75(4):771-3. PubMed ID: 22413911
[TBL] [Abstract][Full Text] [Related]
8. Antineoplastic agents. 550. Synthesis of 10b(s)-epipancratistatin from (+)-narciclasine.
Pettit GR; Melody N; Herald DL; Knight JC; Chapuis JC
J Nat Prod; 2007 Mar; 70(3):417-22. PubMed ID: 17346078
[TBL] [Abstract][Full Text] [Related]
9. Pseudolycorine
Katoch D; Kumar D; Padwad YS; Singh B; Sharma U
Nat Prod Res; 2020 Jul; 34(14):2051-2058. PubMed ID: 30784301
[TBL] [Abstract][Full Text] [Related]
10. Narciclasine as well as other Amaryllidaceae isocarbostyrils are promising GTP-ase targeting agents against brain cancers.
Van Goietsenoven G; Mathieu V; Lefranc F; Kornienko A; Evidente A; Kiss R
Med Res Rev; 2013 Mar; 33(2):439-55. PubMed ID: 22419031
[TBL] [Abstract][Full Text] [Related]
11. Lycorine and its derivatives for anticancer drug design.
Lamoral-Theys D; Decaestecker C; Mathieu V; Dubois J; Kornienko A; Kiss R; Evidente A; Pottier L
Mini Rev Med Chem; 2010 Jan; 10(1):41-50. PubMed ID: 20105122
[TBL] [Abstract][Full Text] [Related]
12. Haemanthus coccineus extract and its main bioactive component narciclasine display profound anti-inflammatory activities in vitro and in vivo.
Fuchs S; Hsieh LT; Saarberg W; Erdelmeier CA; Wichelhaus TA; Schaefer L; Koch E; Fürst R
J Cell Mol Med; 2015 May; 19(5):1021-32. PubMed ID: 25754537
[TBL] [Abstract][Full Text] [Related]
13. Narciclasine-4-
Katoch D; Kumar D; Padwad YS; Singh B; Sharma U
Nat Prod Res; 2020 Jan; 34(2):233-240. PubMed ID: 30636443
[TBL] [Abstract][Full Text] [Related]
14. Targeting of eEF1A with Amaryllidaceae isocarbostyrils as a strategy to combat melanomas.
Van Goietsenoven G; Hutton J; Becker JP; Lallemand B; Robert F; Lefranc F; Pirker C; Vandenbussche G; Van Antwerpen P; Evidente A; Berger W; Prévost M; Pelletier J; Kiss R; Kinzy TG; Kornienko A; Mathieu V
FASEB J; 2010 Nov; 24(11):4575-84. PubMed ID: 20643906
[TBL] [Abstract][Full Text] [Related]
15. Biological evaluation of ent-narciclasine, ent-lycoricidine, and certain enantiomerically-related congeners.
Matveenko M; Banwell MG; Joffe M; Wan S; Fantino E
Chem Biodivers; 2009 May; 6(5):685-91. PubMed ID: 19479847
[TBL] [Abstract][Full Text] [Related]
16. Antineoplastic agents 500. Narcistatin.
Pettit GR; Melody N; Simpson M; Thompson M; Herald DL; Knight JC
J Nat Prod; 2003 Jan; 66(1):92-6. PubMed ID: 12542352
[TBL] [Abstract][Full Text] [Related]
17. Narciclasine, an isocarbostyril alkaloid, has preferential activity against primary effusion lymphoma.
Gopalakrishnan R; Matta H; Choi S; Chaudhary PM
Sci Rep; 2020 Mar; 10(1):5712. PubMed ID: 32235878
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic analysis reveals key early events of narciclasine signaling in Arabidopsis root apex.
Cao X; Ma F; Xu T; Wang J; Liu S; Li G; Su Q; Qiao Z; Na X
Plant Cell Rep; 2016 Nov; 35(11):2381-2401. PubMed ID: 27562382
[TBL] [Abstract][Full Text] [Related]
19. Antineoplastic agents. 527. Synthesis of 7-deoxynarcistatin, 7-deoxy-trans-dihydronarcistatin, and trans-dihydronarcistatin 1(1).
Pettit GR; Melody N
J Nat Prod; 2005 Feb; 68(2):207-11. PubMed ID: 15730244
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic agents of the crinane series of amaryllidaceae alkaloids.
Nair JJ; Bastida J; Viladomat F; van Staden J
Nat Prod Commun; 2012 Dec; 7(12):1677-88. PubMed ID: 23413581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
